These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7311898)

  • 1. [Comparative study of the action of Candida tropicalis K-41 polysaccharides on the infectivity of the tobacco mosaic virus and its RNA].
    Kovalenko AG; Barkalova AA; Mikheeva II
    Mikrobiol Zh (1978); 1981; 43(5):633-9. PubMed ID: 7311898
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nature of the action of Candida tropicalis K-41 mannan on tobacco mosaic virus infectivity].
    Kovalenko AG; Barkalova AA; Bobyr' AD; Votselko SK
    Mikrobiol Zh (1978); 1981; 43(5):627-32. PubMed ID: 7311897
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the action of yeast polysaccharides of different structures on the tobacco mosaic virus].
    Kovalenko AG; Barkalova AA; Koloshin VG; Vitovskaia GA; Elinov NP
    Mikrobiol Zh; 1974; 36(4):490-7. PubMed ID: 4465682
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of some polysaccharide containing complexes of microbial origin on the tobacco mosaic virus and on the influenza virus].
    Mil'chenko KP; Afonskaia SV
    Mikrobiol Zh; 1976; 38(3):347-50. PubMed ID: 948273
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular weight and several features of the structure of yeast polysaccharides possessing antiviral properties].
    Kovalenko AG; Votselko SK
    Prikl Biokhim Mikrobiol; 1977; 13(1):46-54. PubMed ID: 325548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative antiviral activity of the Penicillium funiculosum virus and its RNA].
    Sadovskiĭ IuP; Kovalenko AG
    Mikrobiol Zh; 1974; 36(3):341-6. PubMed ID: 4465667
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiviral substances produced by Candida tropicalis K-41 yeasts. I. The isolation, purification and antiviral activity of the preparations].
    Kovalenko AG
    Mikrobiol Zh; 1978; 40(1):85-91. PubMed ID: 634175
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of preparations of the virus of Penicillium funiculosum on the tobacco mosaic virus].
    Sadovskiĭ IuP; Kovalenko AG; Bobyr' AD; Zakordonets OA
    Mikrobiol Zh; 1973; 35(3):336-41. PubMed ID: 4791363
    [No Abstract]   [Full Text] [Related]  

  • 9. [Defective mutant of the thermotolerant strain of the tobacco mosaic virus. RNA inactivation by a cationic detergent].
    Kapitsa OS; Vostrova NG
    Vopr Virusol; 1973; 18(6):660-3. PubMed ID: 4789970
    [No Abstract]   [Full Text] [Related]  

  • 10. Electron microscopy and infectivity studies of the action of dimethylsulphoxide on two strains of tobacco mosaic virus.
    Nicolaïeff A; Lebeurier G; Hirth L
    J Gen Virol; 1974 Jan; 22(1):43-53. PubMed ID: 4360394
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical degradation of tobacco mosaic virus followed by infectivity assay, reverse transcription-polymerase chain reaction and gel electrophoresis.
    Choi CW; Park SH; Choi JK; Ryu KH; Park WM
    Acta Virol; 2000; 44(3):145-9. PubMed ID: 11155356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of polysaccharide-containing fractions from Gram negative bacteria on adenovirus type 3 and tobacco mosaic virus].
    Mil'chenko KP; Kahanskaia MB
    Mikrobiol Zh; 1970; 32(3):366-9. PubMed ID: 4931218
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isolation, purification and some properties of antiviral substances from the yeast].
    Kovalenko AG
    Mikrobiol Zh; 1971; 33(1):75-82. PubMed ID: 5559346
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of aurintricarboxylic acid on the synthesis of virus-specific subgenome RNA in the tobacco mosaic virus].
    Miroshnichenko NA; Dorokhov IuL; Aleksandrova NM; Atabekov IG
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (10):23-7. PubMed ID: 7306605
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovery of bitriazolyl compounds as novel antiviral candidates for combating the tobacco mosaic virus.
    Xia Y; Fan Z; Yao J; Liao Q; Li W; Qu F; Peng L
    Bioorg Med Chem Lett; 2006 May; 16(10):2693-8. PubMed ID: 16504509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of ZH14 with antiviral activity against Tobacco mosaic virus.
    Zhou WW; Zhang LX; Zhang B; Wang F; Liang ZH; Niu TG
    Can J Microbiol; 2008 Jun; 54(6):441-9. PubMed ID: 18535629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the products of the vital activity of yeasts on the tobacco mosaic virus].
    Bobyr' AD; Glushak LE
    Mikrobiol Zh; 1965; 27(2):73-8. PubMed ID: 5869334
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of tobacco mosaic virus by a bacterial extract.
    Mann EW
    Phytopathology; 1969 May; 59(5):658-62. PubMed ID: 5786563
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of laurusin (formycin B) on tobacco mosaic virus multiplication and its symptom development.
    Huang KT; Katagiri M; Misato T
    J Antibiot (Tokyo); 1966 Mar; 19(2):75-7. PubMed ID: 5952895
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of triazole on RNA viruses.
    Menzel G; Kluge S
    Acta Virol; 1980 Dec; 24(6):445-50. PubMed ID: 6111205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.